Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles
Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles
复制标题
DOI:
10.1073/pnas.1014598108
复制
发表时间:
2011-06-14
影响因子:
11.1
通讯作者:
Tarasova, Nadya I.
中科院分区:
文献类型:
--
作者:
Tarasov, Sergey G.;Gaponenko, Vadim;Tarasova, Nadya I.
Significant efforts have been devoted to the development of nanoparticular delivering systems targeting tumors. However, clinical application of nanoparticles is hampered by insufficient size homogeneity, difficulties in reproducible synthesis and manufacturing, frequent high uptake in the liver, systemic toxicity of the carriers (particularly for inorganic nanoparticles), and insufficient selectivity for tumor cells. We have found that properly modified synthetic analogs of transmembrane domains of membrane proteins can self-assemble into remarkably uniform spherical nanoparticles with innate biological activity. Self-assembly is driven by a structural transition of the peptide that adopts predominantly a beta-hairpin conformation in aqueous solutions, but folds into an alpha-helix upon spontaneous fusion of the nanoparticles with cell membrane. A 24-amino acid peptide corresponding to the second transmembrane helix of the CXCR4 forms self-assembled particles that inhibit CXCR4 function in vitro and hamper CXCR4-dependent tumor metastasis in vivo. Furthermore, such nanoparticles can encapsulate hydrophobic drugs, thus providing a delivery system with the potential for dual biological activity.